These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 24728596)

  • 1. Cytokine storm plays a direct role in the morbidity and mortality from influenza virus infection and is chemically treatable with a single sphingosine-1-phosphate agonist molecule.
    Oldstone MB; Rosen H
    Curr Top Microbiol Immunol; 2014; 378():129-47. PubMed ID: 24728596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Animal model of respiratory syncytial virus: CD8+ T cells cause a cytokine storm that is chemically tractable by sphingosine-1-phosphate 1 receptor agonist therapy.
    Walsh KB; Teijaro JR; Brock LG; Fremgen DM; Collins PL; Rosen H; Oldstone MB
    J Virol; 2014 Jun; 88(11):6281-93. PubMed ID: 24672024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three phases of CD8 T cell response in the lung following H1N1 influenza infection and sphingosine 1 phosphate agonist therapy.
    Matheu MP; Teijaro JR; Walsh KB; Greenberg ML; Marsolais D; Parker I; Rosen H; Oldstone MB; Cahalan MD
    PLoS One; 2013; 8(3):e58033. PubMed ID: 23533579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quelling the storm: utilization of sphingosine-1-phosphate receptor signaling to ameliorate influenza virus-induced cytokine storm.
    Walsh KB; Teijaro JR; Rosen H; Oldstone MB
    Immunol Res; 2011 Oct; 51(1):15-25. PubMed ID: 21901448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping the innate signaling cascade essential for cytokine storm during influenza virus infection.
    Teijaro JR; Walsh KB; Rice S; Rosen H; Oldstone MB
    Proc Natl Acad Sci U S A; 2014 Mar; 111(10):3799-804. PubMed ID: 24572573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Battling COVID-19 Pandemic: Sphingosine-1-Phosphate Analogs as an Adjunctive Therapy?
    Naz F; Arish M
    Front Immunol; 2020; 11():1102. PubMed ID: 32670273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissecting influenza virus pathogenesis uncovers a novel chemical approach to combat the infection.
    Oldstone MB; Teijaro JR; Walsh KB; Rosen H
    Virology; 2013 Jan; 435(1):92-101. PubMed ID: 23217619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cytokine storm of severe influenza and development of immunomodulatory therapy.
    Liu Q; Zhou YH; Yang ZQ
    Cell Mol Immunol; 2016 Jan; 13(1):3-10. PubMed ID: 26189369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sphingosine-1 phosphate and central nervous system.
    Martin R; Sospedra M
    Curr Top Microbiol Immunol; 2014; 378():149-70. PubMed ID: 24728597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Mechanism behind Influenza Virus Cytokine Storm.
    Gu Y; Zuo X; Zhang S; Ouyang Z; Jiang S; Wang F; Wang G
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection.
    Teijaro JR; Walsh KB; Cahalan S; Fremgen DM; Roberts E; Scott F; Martinborough E; Peach R; Oldstone MB; Rosen H
    Cell; 2011 Sep; 146(6):980-91. PubMed ID: 21925319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interindividual immunogenic variants: Susceptibility to coronavirus, respiratory syncytial virus and influenza virus.
    Darbeheshti F; Mahdiannasser M; Uhal BD; Ogino S; Gupta S; Rezaei N
    Rev Med Virol; 2021 Nov; 31(6):e2234. PubMed ID: 33724604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus.
    Walsh KB; Teijaro JR; Wilker PR; Jatzek A; Fremgen DM; Das SC; Watanabe T; Hatta M; Shinya K; Suresh M; Kawaoka Y; Rosen H; Oldstone MB
    Proc Natl Acad Sci U S A; 2011 Jul; 108(29):12018-23. PubMed ID: 21715659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of cytokine responses during influenza virus pathogenesis and potential therapeutic options.
    Teijaro JR
    Curr Top Microbiol Immunol; 2015; 386():3-22. PubMed ID: 25267464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cytokine storm in avian influenza].
    Us D
    Mikrobiyol Bul; 2008 Apr; 42(2):365-80. PubMed ID: 18697437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of host trypsin-type serine proteases and influenza virus-cytokine-trypsin cycle in influenza viral pathogenesis. Pathogenesis-based therapeutic options.
    Kido H; Takahashi E; Kimoto T
    Biochimie; 2019 Nov; 166():203-213. PubMed ID: 31518617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lessons learned and concepts formed from study of the pathogenesis of the two negative-strand viruses lymphocytic choriomeningitis and influenza.
    Oldstone MB
    Proc Natl Acad Sci U S A; 2013 Mar; 110(11):4180-3. PubMed ID: 23341590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining the kinetic effects of infection with influenza virus A/PR8/34 (H1N1) on sphingosine-1-phosphate signaling in mice by targeted LC/MS.
    Gowda D; Ohno M; B Gowda SG; Chiba H; Shingai M; Kida H; Hui SP
    Sci Rep; 2021 Oct; 11(1):20161. PubMed ID: 34635791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy.
    Proia RL; Hla T
    J Clin Invest; 2015 Apr; 125(4):1379-87. PubMed ID: 25831442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the SphK-S1P-SIPR Pathway as a Potential Therapeutic Approach for COVID-19.
    McGowan EM; Haddadi N; Nassif NT; Lin Y
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.